Unknown

Dataset Information

0

Intraoperative Electron Radiotherapy (IOERT) in the Treatment of Primary Breast Cancer.


ABSTRACT: IOERT (intraoperative electron radiotherapy) in breast cancer is used either as a boost (10-12 Gy) followed by whole breast irradiation (WBI) or as full-dose partial breast irradiation (PBI, 20-24 Gy) during breast-conserving surgery. IOERT has the longest evidence of all IORT techniques. When administered as a boost, excellent low local recurrence rates were observed in long-term follow-up >5 years. Even in high-risk groups like triple-negative or locally advanced breast cancers, IOERT contributes to long-term local control rates of more than 90%. For selected low-risk groups, IOERT as PBI with 21 Gy seems to be a viable treatment alternative to standard WBI. IOERT has been shown to be advantageous for several reasons: Geographic misses are avoided due to direct visualization of the tumor bed; thus, a high single dose is delivered with utmost precision to small volumes, completely sparing the skin and ensuring good long-term cosmetic outcome. Furthermore, high single doses seem to induce biological mechanisms with verifiable antitumor capability in in-vitro cell-line studies. In addition, IOERT markedly shortens the overall treatment time both in combination with (now mostly hypofractionated) WBI or as a PBI in selected low-risk constellations.

SUBMITTER: Kaiser J 

PROVIDER: S-EPMC6062668 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Intraoperative Electron Radiotherapy (IOERT) in the Treatment of Primary Breast Cancer.

Kaiser Julia J   Reitsamer Roland R   Kopp Peter P   Gaisberger Christoph C   Kopp Michael M   Fischer Thorsten T   Zehentmayr Franz F   Sedlmayer Felix F   Fastner Gerd G  

Breast care (Basel, Switzerland) 20180530 3


IOERT (intraoperative electron radiotherapy) in breast cancer is used either as a boost (10-12 Gy) followed by whole breast irradiation (WBI) or as full-dose partial breast irradiation (PBI, 20-24 Gy) during breast-conserving surgery. IOERT has the longest evidence of all IORT techniques. When administered as a boost, excellent low local recurrence rates were observed in long-term follow-up >5 years. Even in high-risk groups like triple-negative or locally advanced breast cancers, IOERT contribu  ...[more]

Similar Datasets

| S-EPMC6536702 | biostudies-literature
| S-EPMC4115764 | biostudies-other
| S-EPMC5743678 | biostudies-other
2018-08-30 | GSE119204 | GEO
| S-EPMC5244574 | biostudies-literature
| S-EPMC7268450 | biostudies-literature
| S-EPMC7089893 | biostudies-literature
| S-EPMC9975253 | biostudies-literature
| S-EPMC7830040 | biostudies-literature
| S-EPMC9685863 | biostudies-literature